MoveDMD Trial Open-Label Extension Results (October 2017) PPMD and Catabasis Pharmaceuticals hosted a webinar on October 11, 2017 to hear a community update on the results from the open-label extension of the MoveDMD trial. Research & Clinical Trial Webinars,Webinars 7 years ago You may also like 59:40 Vamorolone Clinical Trials in Duchenne (January 2019) 6 years ago Research & Clinical Trial Webinars,Webinars 44:17 Translarna® (ataluren) Development Update (January 2019) 6 years ago Research & Clinical Trial Webinars,Webinars 1:04:43 The Heart of the Matter – PPMD’s Research Priorities (December 2018) 6 years ago Research & Clinical Trial Webinars,Webinars 1:01:12 Engaging Families in Care Guideline Development (November 2018) 6 years ago Care Webinars,Research & Clinical Trial Webinars,Webinars 47:47 PolarisDMD: Phase 3 Clinical Trial of Edasalonexent, a Novel NF-kB Inhibitor (November 2018) 6 years ago Research & Clinical Trial Webinars,Webinars 56:15 An Update on Corticosteroids (October 2018) 6 years ago Care Webinars,Research & Clinical Trial Webinars,Webinars 44:29 Is Myostatin Still a Potential Therapeutic Target? (October 2018) 6 years ago Research & Clinical Trial Webinars,Webinars 1:00:51 Puberty and Duchenne (September 2018) 6 years ago Care Webinars,Webinars «1…1415161718…25»Page 16 of 25
by: Parent Project Muscular Dystrophy
